
Dechra also bought stem cell developer Gallant, bringing gingivostomatitis and osteoarthritis programs for dogs and cats into its pipeline.
New guidelines give veterinarians a tool for managing these cases in dogs.
Untitled Document
“For the first time, clinicians have a classification system for dogs with chronic valvular heart disease that ties disease stage with specific diagnosis and treatment recommendations. The guidelines give veterinarians a new tool to better tackle these tough cases with confidence and consistency.”
-Hot Literature update
From






